The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt
Danijela Maksimović‐Ivanić(Institute for Biological Research “Siniša Stanković”), Ferdinando Nicoletti(University of Catania), Gordana Timotijević(Northwell Health), James A. McCubrey(East Carolina University), Ljubica Harhaji‐Trajkovic(University of Belgrade), Gianni Garotta(Roche (Switzerland)), Katia Mangano(University of Catania), Darrin Dabideen, Sanja Mijatović(University of Belgrade), Kai Cheng(Chinese Academy of Sciences), Stanislava Stošić‐Grujičić(Institute for Biological Research “Siniša Stanković”), Marija Mojić(Northwell Health), Yousef Al‐Abed(Feinstein Institute for Medical Research), Djordje Miljković(University of Belgrade), Massimo Libra(University of Catania)
Cited by 42
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508